Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
4D Molecular Therapeutics, Inc. | FDMT | 571.11K | $7.6M |
Cogent Biosciences, Inc. | COGT | 493.66K | $19.1M |
Heron Therapeutics, Inc. | HRTX | 458.72K | $195.78K |
Viking Therapeutics, Inc. | VKTX | 441.81K | $17.23M |
Relmada Therapeutics, Inc. | RLMD | 361.37K | $2.5M |
BioMarin Pharmaceutical Inc. | BMRN | 312.85K | $17.9M |
Ardelyx, Inc. | ARDX | 303.02K | $1.55M |
Corvus Pharmaceuticals, Inc. | CRVS | 294.81K | $4.4M |
Edgewise Therapeutics, Inc. | EWTX | 272.21K | $11.06M |
Immunocore Holdings plc | IMCR | 254.86K | $8.09M |
Relay Therapeutics, Inc. | RLAY | 230.68K | $4.32M |
Arcus Biosciences, Inc. | RCUS | 223.81K | $6.9M |
Kodiak Sciences Inc. | KOD | 218.12K | $8.5M |
Ocugen, Inc. | OCGN | 200K | $306K |
Abivax S.A. | ABVX | 163.64K | $21.6M |
Prothena Corporation plc | PRTA | 149.48K | $1.46M |
BioAge Labs Inc. | BIOA | 146.33K | $3.59M |
Zymeworks Inc. | ZYME | 142.13K | $3.72M |
Revolution Medicines, Inc. | RVMD | 139.22K | $26.07M |
Precigen, Inc. | PGEN | 135.29K | $771.17K |